Gupta Suneel

Average Profitability
243.28%
Insider Buys Quantity
1
Insider Buys Sum
$307,800.00
Insider Sells Quantity
3
Insider Sells Sum
$5.76M

Insider Activity of Gupta Suneel

According to the SEC Form 4 filings, Gupta Suneel, being in a position of

  1. Chief Development Officer at Protagonist Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 127628 shares for $5.76M,
    over all time since 2019-12-03, has bought 60000 shares for $307,800, and sold 127628 shares for $5.76M.

The largest purchase of all time was on 2019-12-03 and amounted to 60000 shares of Protagonist Therapeutics, Inc. for $307,800.

The largest sale of all time was on 2024-11-25 and amounted to 103437 shares of Protagonist Therapeutics, Inc. for $4.76M.

Biography of Gupta Suneel

No biography is available at this moment.

2024-11-26SaleProtagonist Therapeutics, Inc.
PTGX
Chief Development Officer
19,191
0.0328%
$45.50$873,191-7.52%
2024-11-25SaleProtagonist Therapeutics, Inc.
PTGX
Chief Development Officer
103,437
0.1742%
$46.04$4.76M-8.91%
2024-01-09SaleProtagonist Therapeutics, Inc.
PTGX
Chief Development Officer
5,000
0.0084%
$25.00$125,000+23.88%
2019-12-03PurchaseProtagonist Therapeutics, Inc.
PTGX
EVP Clinical Operations
60,000
0.2377%
$5.13$307,800+243.28%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.